75 results on '"Bordone, A"'
Search Results
2. The effect of grandparental involvement on grandchildren's school grades: Heterogeneity by the extended family characteristics
3. PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas
4. Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
5. Inborn Errors of Immunity Contribute to the Burden of Skin Disease and Create Opportunities for Improving the Practice of Dermatology
6. Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
7. GPR68 Senses Flow and Is Essential for Vascular Physiology
8. Assessment of safety and efficacy of Janus Kinase inhibitors in patients with alopecia areata over the age of 60 years
9. Smarter every day: The deceleration of population ageing in terms of cognition
10. Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma
11. Tofacitinib therapy for alopecia areata is not associated with adverse events during COVID-19 infection
12. PHASE 2 OPEN-LABEL EXTENSION OF DONIDALORSEN IN PATIENTS WITH HEREDITARY ANGIOEDEMA: A WEEK 197 ANALYSIS
13. DONIDALORSEN FOR HEREDITARY ANGIOEDEMA: RESULTS FROM THE OASISPLUS OPEN-LABEL EXTENSION STUDY
14. DONIDALORSEN EXPOSURE-RESPONSE ANALYSIS: HEREDITARY ANGIOEDEMA ATTACK RATE VERSUS PLASMA PREKALLIKREIN CONCENTRATION RELATIONSHIP
15. Ischemic conditioning protects the rat retina in an experimental model of early type 2 diabetes
16. Treatment of insulin resistance with tirzepatide leading to improvement of hair loss
17. Phase 2 Open-Label Extension Study With Donidalorsen in Patients With Hereditary Angioedema: 1 Year Versus 2 Years
18. SIRT4 Regulates Fatty Acid Oxidation and Mitochondrial Gene Expression in Liver and Muscle Cells
19. Medical comorbidities and sex distribution among patients with lichen planopilaris and frontal fibrosing alopecia: A retrospective cohort study
20. Prevalence estimates for lichen planopilaris and frontal fibrosing alopecia in a New York City health care system
21. Gab2-Mediated Signaling Promotes Melanoma Metastasis
22. TWO-YEAR ANALYSIS OF DONIDALORSEN TAKEN EVERY 8 WEEKS (Q8W) IN PATIENTS WITH HEREDITARY ANGIOEDEMA
23. TWO-YEAR ANALYSIS OF THE DONIDALORSEN PHASE 2 OPEN-LABEL EXTENSION STUDY IN PATIENTS WITH HEREDITARY ANGIOEDEMA
24. Comparison of Three Sequencing Panels Used for the Assessment of Tumor Mutational Burden in NSCLC Reveals Low Comparability
25. 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
26. Oral tofacitinib effectively treating eruptive and hypertrophic cutaneous lichen planus
27. Two cases of bullous pemphigoid effectively treated with oral tofacitinib
28. Phase 2 Open-Label Extension Study With Donidalorsen Treatment in Patients With Hereditary Angioedema: Pharmacodynamic Data
29. The Impact of Donidalorsen Taken Every 8 Weeks in Patients With Hereditary Angioedema
30. Phase 2 Open-Label Extension Study With Donidalorsen in Patients With Hereditary Angioedema: Updated Interim Analysis With Quality-of-Life Data
31. Clinical response to oral tofacitinib in pediatric patients with alopecia areata
32. Effective treatment of alopecia universalis with oral upadacitinib
33. PHASE 2 OPEN-LABEL EXTENSION STUDY WITH DONIDALORSEN TREATMENT IN PATIENTS WITH HEREDITARY ANGIOEDEMA
34. EP11.01-006 Setting Up an Ultra-Fast Next-Generation Sequencing Approach as a Reflex Testing at Diagnosis in Non-squamous Non-small Cell Lung Cancer
35. 567 Gut dysbiosis is associated with the development of alopecia areata
36. Alopecia areata after SARS-CoV-2 vaccination
37. The Impact on Quality of Life Following Treatment with Plasma Prekallikrein Targeted Oligonucleotide Antisense Therapy in Hereditary Angioedema Patients
38. An Open-label Trial With Plasma Prekallikrein Oligonucleotide Antisense Therapy To Control Angioedema Attacks In Hereditary Angioedema Patients With Normal C1-inhibitor
39. Pharmacodynamics and Pharmacokinetics of PKK-LRx in Patients with Hereditary Angioedema
40. DNA Ligase III Is Degraded by Calpain during Cell Death Induced by DNA-damaging Agents
41. A020 A PHASE 2 STUDY EVALUATING AN ANTISENSE OLIGONUCLEOTIDE TO PREKALLIKREIN IN PATIENTS WITH HEREDITARY ANGIOEDEMA
42. Embryonic cocaine exposure and corticosterone: Serotonin 2 receptor mediation
43. 25580 Prevalence estimates for lichen planopilaris and frontal fibrosing alopecia in the United States
44. 693 Gut dysbiosis plays a role in the development of alopecia areata
45. 462 Clinical improvement in primary cicatricial alopecias following mast cell stabilizer treatment
46. 035 Expansion of bacterial phosphatidylglycerol reactive CD4+ T cells in atopic dermatitis
47. The Kinetics of Copper-Induced LDL Oxidation Depend upon Its Lipid Composition and Antioxidant Content
48. A der(11)t(4;11)(q21;p15) in a T-ALL/LBL patient
49. 18763 Validation of case identification for alopecia areata using International Classification of Diseases (ICD) coding
50. ABCL-255: Prognostic Significance of PET CT in Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin Lymphoma Before Transplantation of Autologous Hematopoietic Progenitors: Experience of a Public Hospital
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.